Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) Director Douglas Roeder acquired 13,953 shares of Senseonics Holdings, Inc. Common Stock stock in a transaction on Wednesday, August 19th. The shares were bought at an average cost of $8.98 per share, for a total transaction of $125,297.94. Following the completion of the purchase, the director directly owned 171,191 shares of the company's stock, valued at $1,537,295.18. The trade was a 8.87% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Senseonics Holdings, Inc. Common Stock Price Performance
NASDAQ:SENS opened at $8.82 on Friday. The company has a market cap of $368.68 million, a price-to-earnings ratio of -3.96 and a beta of 1.01. The company has a debt-to-equity ratio of 0.62, a current ratio of 6.74 and a quick ratio of 6.40. The company has a 50 day moving average of $6.06. Senseonics Holdings, Inc. Common Stock has a 1 year low of $4.79 and a 1 year high of $11.58.
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.63) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.08). The company had revenue of $14.48 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. As a group, analysts expect that Senseonics Holdings, Inc. Common Stock will post -2.29 earnings per share for the current fiscal year.
Institutional Trading of Senseonics Holdings, Inc. Common Stock
A number of hedge funds and other institutional investors have recently bought and sold shares of SENS. Penn Capital Management Company LLC bought a new stake in shares of Senseonics Holdings, Inc. Common Stock during the second quarter worth $535,000. SPX Gestao de Recursos Ltda bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter worth about $1,180,000. Stonepine Capital Management LLC purchased a new position in Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth about $276,502,000. Jefferies Financial Group Inc. purchased a new position in Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth about $102,000. Finally, Bank of America Corp DE bought a new stake in Senseonics Holdings, Inc. Common Stock during the 2nd quarter valued at about $2,241,000. Hedge funds and other institutional investors own 12.36% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on SENS shares. Stifel Nicolaus lowered their target price on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a "hold" rating for the company in a report on Monday, May 11th. HC Wainwright reduced their price objective on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a "buy" rating on the stock in a research report on Tuesday, May 12th. Wall Street Zen raised shares of Senseonics Holdings, Inc. Common Stock from a "strong sell" rating to a "sell" rating in a research note on Saturday, August 8th. Mizuho dropped their target price on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an "outperform" rating for the company in a research report on Wednesday, July 15th. Finally, Weiss Ratings cut Senseonics Holdings, Inc. Common Stock from a "sell (d-)" rating to a "sell (e+)" rating in a research note on Wednesday, August 12th. Four research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Senseonics Holdings, Inc. Common Stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $17.20.
Read Our Latest Research Report on Senseonics Holdings, Inc. Common Stock
About Senseonics Holdings, Inc. Common Stock
(
Get Free Report)
Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.
Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
